Slow Income Lab
CSP candidates for the trading week of October 5, 2026
The top 5 candidates from each account universe as of Friday's market close, October 2.
Prices will have moved by Monday's open — treat these as a starting shortlist, not live quotes.
Small Account universe (stocks $20–$200 · up to ~$20K capital per position)
INTC dominates today's top 5, with a $110 cash‑secured put offering a 27‑day DTE, 0.29 delta and an IV rank of 41 that translates to a 47.3% annualized yield; the primary yield driver is the short DTE which compresses premium while still providing a respectable delta. The short‑dated option places the contract in the upper third of INTC’s 52‑week range, supporting the relatively high yield despite modest implied volatility. This is a returning candidate, as no new tickers entered the top five this cycle.
INTC60.3%
$110 put · Oct 30 (26d) · credit $4.72 · capital $11,000
Big Account universe
TSLA, META, AAPL and SPY occupy the top four spots, with TSLA leading thanks to a relatively high delta of 0.30 that lifts its annualized yield to 30.5% despite a modest IV rank of 40, while META’s elevated IV rank of 79 drives its 26.6% yield; AAPL’s moderate IV rank of 49 yields 17.0% and SPY’s higher delta of 0.29 produces a 9.8% yield. All four tickers are new entries to the top‑5 this cycle, and each is positioned at the indicated point in its 52‑week range (TSLA mid‑range, META upper third, AAPL near its high, SPY near its high).
TSLA31.4%
$350 put · Nov 6 (33d) · credit $9.95 · capital $35,000
META27.4%
$680 put · Nov 6 (33d) · credit $16.85 · capital $68,000
AAPL17.5%
$320 put · Nov 6 (33d) · credit $5.07 · capital $32,000
SPY10.1%
$756 put · Nov 6 (33d) · credit $6.91 · capital $75,600
See the full screener →
New here? The methodology behind this screen is explained step by step in the
CSP Starter Guide ($4.99 on Kindle, $5 on Buy Me a Coffee).
Already using the screen? Log your positions, dividends, and options premium in the
Dividend & Options Income Tracker
($19, Google Sheets).
This email is a screening result, not investment advice or a recommendation to buy or sell any security.
Options involve risk and are not suitable for all investors. Do your own due diligence.
Data as of Friday's close and may be stale by the time you read this.
